Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Net Margin (2019 - 2025)

Silo Pharma (SILO) has disclosed Net Margin for 7 consecutive years, with 4890.33% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 471036.0% to 4890.33% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5863.5% through Dec 2025, up 22909.0% year-over-year, with the annual reading at 5863.5% for FY2025, 22909.0% up from the prior year.
  • Net Margin hit 4890.33% in Q4 2025 for Silo Pharma, up from 6160.54% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 663832.93% in Q4 2021 to a low of 1321970.81% in Q3 2021.
  • Historically, Net Margin has averaged 37788.11% across 5 years, with a median of 5312.14% in 2022.
  • Biggest five-year swings in Net Margin: crashed -131807891bps in 2021 and later soared 131651591bps in 2022.
  • Year by year, Net Margin stood at 663832.93% in 2021, then tumbled by -101bps to 9218.17% in 2022, then soared by 37bps to 5833.66% in 2023, then crashed by -65bps to 9600.69% in 2024, then skyrocketed by 49bps to 4890.33% in 2025.
  • Business Quant data shows Net Margin for SILO at 4890.33% in Q4 2025, 6160.54% in Q3 2025, and 6681.24% in Q2 2025.